Ignite Creation Date:
2025-12-24 @ 11:44 PM
Ignite Modification Date:
2026-04-08 @ 4:17 PM
Study NCT ID:
NCT00763451
Status:
COMPLETED
Last Update Posted:
2016-12-14
First Post:
2008-09-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin
Sponsor:
Sanofi
Organization: